Lv4
410 积分 2022-06-09 加入
Interleukin-6 and prostate cancer progression
1天前
待确认
Characterization of Patients With Advanced Pancreatic Cancer and High Serum Interleukin-6 Levels
1天前
已完结
Cytokines in pancreatic carcinoma
1天前
已完结
Claudin 18.2 as a novel therapeutic target
19天前
已完结
Potent suppression of neuroendocrine tumors and gastrointestinal cancers by CDH17CAR T cells without toxicity to normal tissues
22天前
已完结
Author Correction: Potent suppression of neuroendocrine tumors and gastrointestinal cancers by CDH17CAR T cells without toxicity to normal tissues
22天前
已完结
Safe and effective in vivo delivery of DNA and RNA using proteolipid vehicles
29天前
已完结
A viral–lipid hybrid delivery system for genetic therapies
29天前
已完结
A phase I clinical trial of autologous chimeric antigen receptor (CAR) T cells genetically engineered to secrete IL-12 and to target the MUC16ecto antigen in patients (pts) with MUC16ecto+ recurrent high-grade serous ovarian cancer (HGSOC)
3个月前
已完结
Safety and Feasibility of Anti-CD19 CAR-T Expressing IL-7 and CCL19 in Patients with Relapsed or Refractory Large B-Cell Lymphoma
3个月前
已关闭
皖公网安备34019202002308
